Evidence map›Paper›PMID 28774749›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2018

Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis.

Traci M Kazmerski, Gregory S Sawicki, Elizabeth Miller, Kelley A Jones, Kaleab Z Abebe, Lisa K Tuchman, Sigrid Ladores, Ronald C Rubenstein, Scott D Sagel, Daniel J Weiner and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Evaluating pregnancy and neonatal outcomes in mothers with genetic disease using electronic health care records.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Cystic fibrosis.Nature reviews. Disease primers · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Gynecologic health care for females with cystic fibrosis.Journal of clinical & translational endocrinology · 2021
    Article
  17. Article
  18. Article
  19. Challenges in the use of highly effective modulator treatment for cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Traci M KazmerskiDivision of Respiratory Diseases, Department of Medicine, Boston Children's Hospital, Boston, MA, United States; Institute for Healthcare Improvement, Cambridge, MA, United States. Electronic address: traci.kazmerski@childrens.harvard.edu.
Gregory S SawickiDivision of Respiratory Diseases, Department of Medicine, Boston Children's Hospital, Boston, MA, United States.
Elizabeth MillerChildren's Hospital of Pittsburgh of UPMC, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States; Center for Women's Health Research and Innovation (CWHRI), University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Kelley A JonesChildren's Hospital of Pittsburgh of UPMC, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Kaleab Z AbebeDepartment of Medicine, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, PA, United States; Center for Research on Health Care Data Center, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Lisa K TuchmanDivision of Adolescent and Young Adult Medicine, Children's National Health System, Washington, DC, United States.
Sigrid LadoresUniversity of Alabama-Birmingham, School of Nursing, Birmingham, AL, United States.
Ronald C RubensteinDivision of Pulmonary Medicine, Cystic Fibrosis Center, The Children's Hospital of Philadelphia, Philadelphia, PA, United States; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Scott D SagelDepartment of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, United States.
Daniel J WeinerChildren's Hospital of Pittsburgh of UPMC, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Joseph M PilewskiDepartment of Medicine, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, PA, United States.
David M OrensteinChildren's Hospital of Pittsburgh of UPMC, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Sonya BorreroCenter for Women's Health Research and Innovation (CWHRI), University of Pittsburgh School of Medicine, Pittsburgh, PA, United States; Department of Medicine, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, PA, United States; VA Pittsburgh Center for Health Equity Research and Promotion, Pittsburgh, PA, United States.

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
NCATS NIH HHS UL1 TR000005
6 · The paper itself

Abstract

backgroundThe prevalence of general and disease-specific sexual and reproductive health (SRH) concerns is unknown in the United States (U.S.) female CF population. This study aimed to describe and compare the SRH experiences and behaviors of young women with CF with the general U.S. POPULATION:

methodsYoung women with CF ages 15-24years from five geographically diverse U.S. CF centers participated in a survey investigating SRH. Results were summarized and compared to the U.S. National Survey of Family Growth (NSFG) using logistic regression adjusting for confounders.

findingsA total of 188 young women with CF (mean age 19.7±2.7years) completed the survey; data were compared to 1997 NSFG respondents (mean age 19.6±0.10years). Fifty-four percent of women with CF reported having had vaginal sex with a male partner compared to 66% of U.S. women (p=0.55). Women with CF were less likely to have ever used contraception (55% vs. 74%, p=0.0001) or have been tested for sexually transmitted infections in the past year (19% vs. 34%, p=0.001) compared to the general population. Two percent of women with CF reported having ever been pregnant compared to 24% of U.S. women (p<0.0001). One-third of young women with CF reported perceived pubertal delay, 16% urinary incontinence, 16% sexual dysfunction, and 49% yeast infections.

interpretationYoung women with CF face significant SRH concerns and appear to be experiencing gaps in SRH care provision. Opportunities exist for intervention development around this aspect of comprehensive CF care.

fundingCF Foundation (KAZMER15A0); U.S. National Institutes of Health (UL1TR000005).

Indexed as

Cystic FibrosisReproductive HealthSexual BehaviorAdolescentFemaleHealth Knowledge, Attitudes, PracticeHumansNeeds AssessmentPregnancyPregnancy RateSurveys and QuestionnairesUnited StatesYoung AdultCystic fibrosisSexual and reproductive healthWomen's health

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.